A detailed history of Keel Point, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Keel Point, LLC holds 5,237 shares of ZTS stock, worth $851,588. This represents 0.09% of its overall portfolio holdings.

Number of Shares
5,237
Previous 5,387 2.78%
Holding current value
$851,588
Previous $933,000 9.65%
% of portfolio
0.09%
Previous 0.08%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$172.58 - $196.48 $25,887 - $29,472
-150 Reduced 2.78%
5,237 $1.02 Million
Q2 2024

Aug 14, 2024

BUY
$145.54 - $178.83 $444,915 - $546,683
3,057 Added 131.2%
5,387 $933,000
Q1 2024

Apr 16, 2024

BUY
$165.67 - $199.94 $26,010 - $31,390
157 Added 7.23%
2,330 $394,000
Q4 2023

Jan 30, 2024

BUY
$151.44 - $200.09 $22,413 - $29,613
148 Added 7.31%
2,173 $428,000
Q3 2023

Oct 26, 2023

SELL
$167.14 - $192.77 $9,694 - $11,180
-58 Reduced 2.78%
2,025 $352,000
Q2 2023

Jul 12, 2023

BUY
$160.94 - $186.23 $30,739 - $35,569
191 Added 10.1%
2,083 $358,000
Q1 2023

Apr 03, 2023

BUY
$145.48 - $175.02 $29,968 - $36,054
206 Added 12.22%
1,892 $314,000
Q4 2022

Jan 17, 2023

BUY
$131.14 - $157.47 $11,802 - $14,172
90 Added 5.64%
1,686 $0
Q3 2022

Oct 05, 2022

BUY
$148.29 - $182.55 $57,239 - $70,464
386 Added 31.9%
1,596 $237,000
Q2 2022

Aug 11, 2022

SELL
$155.97 - $200.09 $45,387 - $58,226
-291 Reduced 19.39%
1,210 $211,000
Q1 2022

Apr 27, 2022

SELL
$181.39 - $234.03 $1,269 - $1,638
-7 Reduced 0.46%
1,501 $283,000
Q4 2021

Jan 31, 2022

BUY
$193.69 - $247.03 $36,994 - $47,182
191 Added 14.5%
1,508 $367,000
Q3 2021

Nov 04, 2021

BUY
$189.29 - $209.69 $249,294 - $276,161
1,317 New
1,317 $256,000
Q2 2021

Aug 06, 2021

SELL
$155.9 - $187.99 $185,676 - $223,896
-1,191 Closed
0 $0
Q2 2021

Aug 06, 2021

BUY
$155.9 - $187.99 $185,676 - $223,896
1,191 New
1,191 $222,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $76.1B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Keel Point, LLC Portfolio

Follow Keel Point, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keel Point, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Keel Point, LLC with notifications on news.